NYSE:DGXHealthcare
Quest Diagnostics (DGX) Stock Earnings Beat Supports Defensive Profitability Narrative
Quest Diagnostics (DGX) has just posted its Q2 2026 numbers, with revenue of US$3.0 billion, basic EPS of US$2.88 and net income of US$320 million setting the tone for the latest update. The company has seen revenue move from US$2.76 billion and EPS of US$2.51 in Q2 2025 to US$3.0 billion and EPS of US$2.88 in Q2 2026. Trailing 12 month revenue sits at US$11.6 billion with basic EPS of US$9.62. With net margin for the trailing period a touch higher than last year and earnings up over the past...